Analyst Ratings for Insmed (INSM)
INSM Rating Summary
INSM Price Target Summary
- Highest: $263.00 (Rothschild Redburn)
- Lowest: $160.00 (Evercore ISI)
- Average: $204.95
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$204.95 (+112.9%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 89%
Rating Score: 9.1 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Wolfe Research | Andy Chen | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
100.60 (96.27) |
-4.3% | Details |
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Buy (N/A) |
188.00 (N/A) |
120.82 (96.27) |
-20.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
